Zofenil Comp. 30+12,5 mg filmovertrukne tabletter דנמרק - דנית - Lægemiddelstyrelsen (Danish Medicines Agency)

zofenil comp. 30+12,5 mg filmovertrukne tabletter

menarini international operation - hydrochlorthiazid, zofenoprilcalcium - filmovertrukne tabletter - 30+12,5 mg

Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals האיחוד האירופי - דנית - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals

glaxosmithkline biologicals s.a. - splittet influenzavirus, inaktiveret, indeholdende antigen: a / vietnam / 1194/2004 (h5n1) som brugt belastning (nibrg-14) - influenza, human; immunization; disease outbreaks - vacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. denne angivelse er baseret på immunogenicitet data fra raske forsøgspersoner i alderen fra 18 år og op efter administration af to doser vaccine, der er fremstillet af en/vietnam/1194/2004 nibrg-14 (h5n1) (se afsnit 5. prepandemic influenza vaccine (h5n1) (split virion, inaktiveret, adjuvanted) glaxosmithkline biologicals 3. 75 µg bør anvendes i overensstemmelse med officielle retningslinjer.

Kenalog 40 mg/ml injektionsvæske, suspension דנמרק - דנית - Lægemiddelstyrelsen (Danish Medicines Agency)

kenalog 40 mg/ml injektionsvæske, suspension

bristol-myers squibb ab - triamcinolonacetonid - injektionsvæske, suspension - 40 mg/ml

Ronapreve האיחוד האירופי - דנית - EMA (European Medicines Agency)

ronapreve

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - immune sera og immunoglobuliner, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. se afsnit 4. 4 og 5.